Vous avez cherché: randomizirano (Slovène - Anglais)

randomizirano
randomised

vse randomizirano
all randomised

randomizirano zdravljenje
randomised treatment†

randomizirano kontrolirano preskušanje
randomized controlled trial

neodvisna onkološka ocena, vse randomizirano
independent oncology review,

oblika preskušanja: randomizirano, globalno, multicentrično, odprto
design: randomised, global multicentre, open-label

dvojno slepo, randomizirano, kontrolirano (botox) preizkušanje
repeated intramuscular injections at 6 and 13 week intervals up to a dose of 0.64 lethal dose unit (ldu)/ animal for xeomin and botox (approx.

eno veliko odprto, multicentrično, mednarodno randomizirano študijo tretje
one large, open-label, multicentre, international randomised phase iii study has been conducted in patients with newly diagnosed ph+ cml.

shire bo opravil randomizirano, primerjalno študijo pri bolnikih z et.
shire will conduct a randomised, comparative study in patients with et.

randomizirano, odprto klinično preskušanje so opravili pri bolnikih z akutno simptomatsko pe.
a randomised, open-label, clinical trial was conducted in patients with acute symptomatic pe.

randomizirano, dvojno slepo s placebom nadzorovano študijo so opravili pri 83 bolnikih s fap.
a randomized double-blind placebo controlled study was conducted in 83 patients with fap.

pri preiskovancih z asimptomatskim hae so opravili randomizirano odprto farmakokinetično študijo zdravila cinryze s paralelnimi skupinami.
a randomised, parallel group, open-label pharmacokinetic study of cinryze was performed in subjects with non-symptomatic hae.

zdravljenje pljučne embolije randomizirano, odprto klinično preskušanje so opravili pri bolnikih z akutno simptomatsko pe.
treatment of pulmonary embolism a randomised, open-label, clinical trial was conducted in patients with acute symptomatic pe.

v randomizirano, s placebom nadzorovano preskušanje z dodatkom zdravila k obstoječemu zdravljenju so vključili 41 otrok s smei.
41 children with smei were included in a randomised, placebo-controlled, add-on trial.

med študijo reset so bolniki opažanja v dnevnik zapisovali povprečno 57 dni med uvajalnim obdobjem in 59 dni med randomizirano fazo prekinitve zdravljenja.
during reset, patient diaries were recorded for an average of 57 days during the run-in phase and 59 days during the randomised-withdrawal phase.

izvedeno je bilo eno samo randomizirano, multicentrično, nadzorovano preskušanje 2. faze belatacepta pri bolnikih z na novo presajenimi jetri.
a single, randomised, multi-center, controlled phase 2 trial of belatacept in de novo orthotopic liver transplant recipients was conducted.

eno veliko odprto, multicentrično, mednarodno randomizirano študijo tretje faze so opravili pri bolnikih z na novo diagnosticirano ph+ kml.
one large, open-label, multicentre, international randomised phase iii study has been conducted in patients with newly diagnosed ph+ cml.

iz stopnje recidivov izpeljane spremenljivke / iz mrt - sekundarni opazovani dogodki izpeljane spremenljivke predmeti randomizirano dopolnjeno 1 leto dopolnjeni 2 leti
completing 1 years completing 2 years

bolniki so randomizirano prejemali injekcije zdravila zypadhera 405 mg vsake 4 tedne, 300 mg vsake 2 tedna, 210 mg vsake 2 tedna ali placebo vsake 2 tedna.
patients were randomized to receive injections of zypadhera 405 mg every 4 weeks, 300 mg every 2 weeks, 210 mg every 2 weeks, or placebo every 2 weeks.

mah bo opravil multicentrično, randomizirano, odprto študijo faze 2a zdravila strensiq pri bolnikih s hipofosfatazijo (hpp) z naslednjima ciljema:
the mah should conduct a multicentre, randomized, open-label, phase 2a study of strensiq in patients with hypophosphatasia (hpp) to: